Switch from oral to inactivated poliovirus vaccine in Yogyakarta province, Indonesia: Summary of coverage, immunity, and environmental surveillance

Journal of Infectious Diseases

Volumn 210, Issue , 2014, Pages S347-S352

  Wahjuhono, Gendro ^a   Revolusiana, ^d   Widhiastuti, Dyah ^g   Sundoro, Julitasari ^b   Mardani, Tri ^d   Ratih, Woro Umi ^e   Sutomo, Retno ^f   Safitri, Ida ^f   Sampurno, Ondri Dwi ^b   Rana, Bardan ^c   Roivainen, Merja ^h   Kahn, Anna Lea ^c   Mach, Ondrej ^c   Pallansch, Mark A ⁱ   Sutter, Roland W ^c  

^a NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^b MINISTRY OF HEALTH   (Indonesia)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d Yogyakarta Provincial Health Office   (Denmark)

^e Provincial Health Laboratory   (United States)

^f GADJAH MADA UNIVERSITY   (Indonesia)

^g Bio Farma   (Indonesia)

^h NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

ⁱ CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

immunization; polio; poliovirus circulation

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; SEWAGE; VIRUS ANTIBODY;

ARTICLE; CHILD; CHILD HEALTH CARE; ENVIRONMENTAL MONITORING; GENE SEQUENCE; HUMAN; IMMUNITY; INDONESIA; INFANT; INFECTION PREVENTION; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; SEQUENCE ANALYSIS; SEROLOGY; SEROPREVALENCE; SEWAGE; VACCINATION; VIRUS ISOLATION; ANIMAL; BLOOD; CLASSIFICATION; FEMALE; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; PRESCHOOL CHILD; PROCEDURES; UTILIZATION; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; CHILD, PRESCHOOL; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; INDONESIA; INFANT; MALE; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, INACTIVATED; SEWAGE; VACCINATION;

EID: 84910603879     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu060     Document Type: Article

References (17)

1. Global polio Eradication Initative. Cases of wild poliovirus by country/year. http://www.polioeradication.org/Dataandmonitoring/Poliothisweek/Wildpolioviruslist.aspx. Accessed 9 November 2013.
2. Global polio Eradication Initative. Polio eradication and endgame: strategic plan 2013-2018. http://w ww.polioeradication.org/Portals/0/Document/Resources/StrategyWork/EndGameStratPlan-WHAversion.pdf Accessed 9 November 2013.
3. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived poliovir uses and the endgame strategy for global polio eradication. Annu Rev Microbiol 2005; 59:587-635.
4. Jenkins HE, Aylward RB, Gasasira A, et al. Implications of a circulating vaccine-derived poliovirus in Nigeria. N Engl J Med 2010; 362:2360-9.
5. Progress toward the global interruption of wild poliovirus type 2 transmission, 1999. MMWR Morb Mortal Wkly Rep 1999; 48:736- 8, 47.
6. Agol VI. Vaccine-derived polioviruses. Biologicals 2006; 34:103-8.
7. Polio eradication: surveys of routine immunization coverage and seroprevalence against polioviruses, Yogyakarta Province, Indonesia. Wkly Epidemiol Rec 2008; 83:45-8.
8. World Health Organiza tion. Dept of Immunization, Vaccines and Biologicals. Immunization coverage cluster survey: reference manual. Geneva, Switzerland: World Health Organization, 2005.
9. Sutomo R, Laksono IS, Sitaresmi MN, Indriani C, Indrawanti R, Ondrej M. The impact of inactivated polio vaccine introduction on the overall expanded program on immunization coverage and timeliness in Yogyakarta province. Jurnal Manajemen Pelayanan Kesehatan 2012; 15: 64-70.
10. Sutter RW, Pallansch MA, Sawyer LA, Cochi SL, Hadler SC. Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination. Ann N Y Acad Sci 1995; 754:289-99.
11. World Health Organization. Dept of Vaccines and Biologicals. Guidelines for environmental surveillance of poliovirus circulation. Geneva, Switzerland: World Health Organization, 2003.
12. Sutomo R, Laksono IS, Sitaresmi MN, Indriani C, Indrawanti R, Ondrej M. A pilot project on inactivated polio vaccine in Yogyakarta province: the coverage and timeliness. Jurnal Manajemen Pelayanan Kes ehatan 2012; 15:27-31.
13. Huang QS,Greening G Baker MG, et al. Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand. Lancet 2005 366 394-6.
14. Wood N, Thorley B. Towards global poliomyelitis eradication: the successes and challenges for a developed country. J Paediatr Child Health 2003; 39:647-50.
15. I ntroduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries. Wkly Epidemiol Rec 2003; 78: 241-50.
16. Windorfer A, Beyrer K. Poliomyelitis-why we must continue to vaccinate! MMW Fortschr Med 2005; 147:36-40.
17. Schoub BD. Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa. Vaccine 2012; 30 (Suppl 3):C35-7.